| Food and Drug Administration--Proposed Rule Stage
|
|
| Sequence Number | Title | Regulation Identifier Number |
|
| 1116
| Hearing Aids; Professional and Patient Labeling; Conditions for Sale
(RegPlan Seq. No. 32) | 0910-AA39 |
|
| 1117
| Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution
| 0910-AA49 |
|
| 1118
| Investigational New Drugs: Export Requirements for Unapproved New Drug Products
| 0910-AA61 |
|
| 1119
| Safety Reporting and Recordkeeping Requirements for Marketed OTC Drugs
| 0910-AA86 |
|
| 1120
| Labeling for Human Prescription Drugs; Revised Format
(RegPlan Seq. No. 33) | 0910-AA94 |
|
| 1121
| Safety Reporting Requirements for Human Drug and Biological Products
(RegPlan Seq. No. 34) | 0910-AA97 |
|
| 1122
| Radioactive Drugs for Basic Research
| 0910-AB00 |
|
| 1123
| Administrative Practices and Procedures; Advisory Opinions and Guidelines
| 0910-AB14 |
|
| 1124
| Current Good Tissue Practice for Manufacturers of Human Cellular and Tissue-Based Products
(RegPlan Seq. No. 35) | 0910-AB28 |
|
| 1125
| Applications for FDA Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications
| 0910-AB34 |
|
| 1126
| Expanded Access to Investigational Therapies
| 0910-AB37 |
|
| 1127
| Electronic Submission of Adverse Drug Reaction Reports
| 0910-AB42 |
|
| 1128
| Distinguishing Marks for Drug Products Containing Insulin
| 0910-AB43 |
|
| 1129
| Pregnancy Labeling
| 0910-AB44 |
|
| 1130
| Pharmacy and Physician Compounding of Drug Products
(RegPlan Seq. No. 36) | 0910-AB58 |
|
| 1131
| Drug Products That Present Demonstrable Difficulties for Compounding Because of Reasons of Safety or Effectiveness
| 0910-AB59 |
|
| 1132
| Discontinuation of a Lifesaving Product
| 0910-AB60 |
|
| 1133
| Positron Emission Tomography Drugs; Current Good Manufacturing Practices
(RegPlan Seq. No. 37) | 0910-AB63 |
|
| 1134
| Current Good Manufacturing Practice for Medicated Feeds
| 0910-AB70 |
|
| 1135
| CGMPs for Blood and Blood Components: Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV (Lookback)
(RegPlan Seq. No. 38) | 0910-AB76 |
|
| 1136
| Fixed-Combination Prescription and Over-the-Counter Drugs for Human Use
| 0910-AB79 |
|
| 1137
| Stability Testing of Drugs
| 0910-AB82 |
|
| 1138
| Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements
(RegPlan Seq. No. 39) | 0910-AB88 |
|
| 1139
| Current Good Manufacturing Practice for Blood and Blood Components; Blood Labeling Standards
| 0910-AB89 |
|
| 1140
| Submission in Electronic Format of Certain Labeling Information
| 0910-AB91 |
|
| 1141
| Fees Relating to Drugs; Waiver and Reduction of Fees
| 0910-AB92 |
|
| 1142
| Periodic Testing for Certain Human Drug, Veterinary Drug, and Biological Product Final Specifications
| 0910-AB93 |
|
| 1143
| Marking Requirements for and Prohibitions on the Reimportation of Imported Food Products That Have Been Refused Admission into the United States
| 0910-AB95 |
|
| 1144
| Requirements Pertaining to Sampling Services and Private Laboratories Used in Connection with Imported Food
| 0910-AB96 |
|
| 1145
| Medical Devices, Medical Device Establishment Registration and Listing Requirements; Amendment
| 0910-AB99 |
|
| 1146
| Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Gene Therapy or Xenotransplantation
(RegPlan Seq. No. 40) | 0910-AC00 |
|
| 1147
| Reporting Information Regarding Potential Fabrication or Falsification
| 0910-AC02 |
|
| 1148
| Examination of Administrative Record and Other Advisory Committee Records
| 0910-AC03 |
|
| 1149
| Status Reports for Quantity Marketed Information for Animal Drug Products Used in Food-Producing Animals
| 0910-AC04 |
|
| 1150
| Additional Safeguards for Children in Clinical Investigations
| 0910-AC07 |
|
| 1151
| Addition to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness
| 0910-AC08 |
|
| 1152
| Labeling Dietary Supplements for Women Who Are or May Become Pregnant
| 0910-AC09 |
|
| 1153
| Overwrap For Inhalation Products Packaged in Low Density Polyethylene (LDPE) Containers
| 0910-AC10 |
|
| 1154
| Revocation of Conditions for Marketing Digoxin Products for Oral Use
| 0910-AC12 |
|
| 1155
| Regulation of Carcinogenic Compounds Used in Food-Producing Animals; Definition of ``No Residue''
| 0910-AC13 |
|
| 1156
| Control of Salmonella Enteritidis in Shell Eggs During Production and Retail
(RegPlan Seq. No. 41) | 0910-AC14 |
|
| 1157
| Premarket Notice Concerning Bioengineered Foods
(RegPlan Seq. No. 42) | 0910-AC15 |
| Food and Drug Administration--Final Rule Stage
|
|
| Sequence Number | Title | Regulation Identifier Number |
|
| 1158
| Over-the-Counter (OTC) Drug Review
| 0910-AA01 |
|
| 1159
| New Animal Drug Approval Process; Implementation of Title I of the Generic Animal Drug and Patent Term Restoration Act (GADPTRA)
| 0910-AA02 |
|
| 1160
| Biological Products: Reporting of Biological Product Deviations in Manufacturing
| 0910-AA12 |
|
| 1161
| Fruit and Vegetable Juices: Development of HACCP and Label Warning Statements for Juices
(RegPlan Seq. No. 43) | 0910-AA43 |
|
| 1162
| Bioavailability and Bioequivalence Requirements
| 0910-AA51 |
|
| 1163
| Drugs Used for Treatment of Narcotic Addicts
| 0910-AA52 |
|
| 1164
| Determination That Informed Consent Is Infeasible or Is Contrary to the Best Interest of Recipients
| 0910-AA89 |
|
| 1165
| Current Good Manufacturing Practice; Revision of Certain Labeling Controls
| 0910-AA98 |
|
| 1166
| Use of Ozone-Depleting Substances
| 0910-AA99 |
|
| 1167
| Establishment Registration and Listing of Human Cells and Tissue
(RegPlan Seq. No. 44) | 0910-AB05 |
|
| 1168
| Veterinary Feed Directives
| 0910-AB09 |
|
| 1169
| Exports; Notification and Recordkeeping Requirements
| 0910-AB16 |
|
| 1170
| Foreign Establishment Registration and Listing
| 0910-AB21 |
|
| 1171
| FDA Export Reform and Enhancement Act of 1996; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Later Export
| 0910-AB24 |
|
| 1172
| Blood Initiative
| 0910-AB26 |
|
| 1173
| Shell Eggs: Warning, Notice and Safe Handling Labeling Statements and Refrigeration Requirements
| 0910-AB30 |
|
| 1174
| Antibiotic Drug Approval and Exclusivity
| 0910-AB33 |
|
| 1175
| Amendment of Regulations Regarding Certain Label Statements on Prescription Drugs
| 0910-AB39 |
|
| 1176
| Supplements and Other Changes to Approved New Animal Drug Applications
| 0910-AB49 |
|
| 1177
| Bulk Drug Substances for Use in Pharmacy Compounding
| 0910-AB57 |
|
| 1178
| Supplements and Other Changes to an Approved Application
| 0910-AB61 |
|
| 1179
| Food Labeling: Trans Fatty Acids in Nutrition Labeling and Nutrient Content Claims
| 0910-AB66 |
|
| 1180
| Presubmission Conferences
| 0910-AB68 |
|
| 1181
| Citizen Petitions; Actions That Can Be Requested by Petition; Denials, Withdrawals, and Referrals for Other Administrative Action
| 0910-AB73 |
|
| 1182
| Surgeon's and Patient Examination Gloves; Reclassification
| 0910-AB74 |
|
| 1183
| 180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications
| 0910-AB80 |
|
| 1184
| Postmarketing Studies for Human Drugs and Licensed Biological Products: Status Reports
| 0910-AB83 |
|
| 1185
| Food Additives: Food Contact Substances Notification System
| 0910-AB94 |
|
| 1186
| State Certification of Mammography Facilities
| 0910-AB98 |
|
| 1187
| Addition to the List of Drug Products That Have Been Withdrawn From the Market for Reasons of Safety or Effectiveness
| 0910-AC01 |
|
| 1188
| Efficacy Evidence Needed for Products To Be Used Against Toxic Substances When Human Studies Are Unethical
| 0910-AC05 |
|
| 1189
| Implementing Court Decisions, ANDA Approvals, and 180-Day Exclusivity
| 0910-AC11 |
| Health Care Financing Administration--Final Rule Stage
|
|
| Sequence Number | Title | Regulation Identifier Number |
|
| 1241
| Payment for Nursing and Allied Health Science Education (HCFA-1685-F)
| 0938-AE79 |
|
| 1242
| Home Health Agency (HHA) Conditions of Participation (HCFA-3819-F)
| 0938-AG81 |
|
| 1243
| Additional Supplier Standards (HCFA-6004-F)
| 0938-AH19 |
|
| 1244
| Requirements for Enrollment of Medicaid Recipients Under Cost Effective Employer-Based Group Health Plans (HCFA-2047-F)
| 0938-AH48 |
|
| 1245
| Terms, Definitions, and Addresses: Technical Amendments (HCFA-9877-FC)
| 0938-AH53 |
|
| 1246
| Update of Ratesetting Methodology, Payment Rates and the List of Covered Surgical Procedures for Ambulatory Surgical Centers Effective for Calendar Year 2000 (HCFA-1885-FC)
(RegPlan Seq. No. 51) | 0938-AH81 |
|
| 1247
| Standard Unique Health Care Provider Identifier (HCFA-0045-F)
| 0938-AH99 |
|
| 1248
| Medicare Program; Adjustments to Cost Limits for Skilled Nursing Facility Inpatient Routine Service Costs (HCFA-1896-FN)
| 0938-AI14 |
|
| 1249
| Medicare Program; Prospective Payment System for Hospital Outpatient Services (HCFA-1005-F)
| 0938-AI56 |
|
| 1250
| National Standard Employer Identifier (HCFA-0047-F)
| 0938-AI59 |
|
| 1251
| Medicaid Program; Home and Community-Based Services (HCFA-2010-FC)
| 0938-AI67 |
|
| 1252
| Medicaid Managed Care; Regulatory Program To Implement Certain Medicaid Provisions of the Balanced Budget Act of 1997 (HCFA-2001-F)
| 0938-AI70 |
|
| 1253
| Expanded Coverage for Diabetes Outpatient Self-Management Training Services (HCFA-3002-P)
(RegPlan Seq. No. 52) | 0938-AI96 |
|
| 1254
| External Quality Review of Medicaid Managed Care Organizations (HCFA-2015-F)
| 0938-AJ06 |
|
| 1255
| Protection for Women Who Elect Reconstruction After a Mastectomy (HCFA-2040-IFC)
(RegPlan Seq. No. 53) | 0938-AJ44 |
|
| 1256
| The Children's Health Insurance Program: Implementing the Balanced Budget Act of 1997 (HCFA-2006-F)
(RegPlan Seq. No. 54) | 0938-AJ75 |
|
| 1257
| Application of Inherent Reasonableness to All Part B Services Other Than Physician Services (HCFA-1908-F)
(RegPlan Seq. No. 55) | 0938-AJ97 |
|
| 1258
| Flexibility in Payment Methods for Services of Hospitals, Nursing Facilities, and Intermediate Care Facilities for the Mentally Retarded (HCFA-2004-F)
| 0938-AK04 |
|
| 1259
| Hospital Conditions of Participation; Anesthesia Services (HCFA-3049-F)
(RegPlan Seq. No. 56) | 0938-AK08 |
|
| 1260
| Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Phase II (HCFA-1810-FC)
(RegPlan Seq. No. 57) | 0938-AK31 |
| Health Care Financing Administration--Long-Term Actions
|
|
| Sequence Number | Title | Regulation Identifier Number |
|
| 1261
| Changes to Peer Review Organization Regulations (HCFA-3135-F)
| 0938-AD38 |
|
| 1262
| ''Without Fault'' and Beneficiary Waiver of Recovery As It Applies to Medicare Overpayment Liability (HCFA-6007-F)
| 0938-AD95 |
|
| 1263
| Protection of Income and Resources for Community Spouses of Institutionalized Individuals (HCFA-2023-P)
| 0938-AE12 |
|
| 1264
| Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) Services (HCFA-2028-F)
| 0938-AE72 |
|
| 1265
| Coverage of Screening Pap Smears (HCFA-3705-F)
| 0938-AE98 |
|
| 1266
| Medicaid Payment for Covered Outpatient Drugs Under Rebate Agreements (HCFA-2046-FC)
| 0938-AF42 |
|
| 1267
| Referral to Child Support Enforcement Agencies of Medicaid Families (HCFA-2051-F)
| 0938-AF68 |
|
| 1268
| Disclosure of Confidential PRO and ESRD Network Organization Information for Research Purposes (HCFA-3208-P)
| 0938-AG33 |
|
| 1269
| Effect of Change of Ownership on Provider and Supplier Penalties, Sanctions, Underpayments and Overpayments (HCFA-2215-P)
| 0938-AG59 |
|
| 1270
| Medicaid: Optional Coverage of TB-Related Services for Individuals Infected With Tuberculosis (HCFA-2082-P)
| 0938-AG72 |
|
| 1271
| Revision of Medicare/Medicaid Hospital Conditions of Participation (HCFA-3745-F)
| 0938-AG79 |
|
| 1272
| Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships-Expanded to Designated Health Services (HCFA-1809-FC)
| 0938-AG80 |
|
| 1273
| Distinct Part Requirements for Nursing Homes and Prohibition on Financial Screening of Applicants for Nursing Home Admission (HCFA-3815-P)
| 0938-AG84 |
|
| 1274
| CLIA Program: Categorization of Waived Tests (HCFA-2225-FC)
| 0938-AG99 |
|
| 1275
| Liability for Third Parties To Pay for Services (HCFA-2080-P)
| 0938-AH01 |
|
| 1276
| State Plan Amendment (SPA) Reconsideration Process (HCFA-2096-P)
| 0938-AH24 |
|
| 1277
| Hospice Care-Conditions of Participation (HCFA-3844-P)
| 0938-AH27 |
|
| 1278
| Medicare Coverage of Services of Speech-Language Pathologists and Audiologists (HCFA-1843-P)
| 0938-AH37 |
|
| 1279
| Medicaid; Estate Recoveries (HCFA-2083-P)
| 0938-AH63 |
|
| 1280
| Individual Market Health Insurance Reform: Portability From Group to Individual Coverage; Federal Rules for Access in the Individual Market; State Alternative Mechanisms to Federal Rules (HCFA-2882-F)
| 0938-AH75 |
|
| 1281
| Revisions to Conditions for Coverage for Ambulatory Surgical Centers (HCFA-3887-P)
| 0938-AH83 |
|
| 1282
| Disclosure of Peer Review Organization Information in Response to Beneficiary Complaints (HCFA-3241-P)
| 0938-AH85 |
|
| 1283
| National Standard for Identifiers of Health Plans (HCFA-4145-P)
| 0938-AH87 |
|
| 1284
| Medicaid Program; Amendment to the Preadmission Screening and Annual Resident Review Program (HCFA-2107-P)
| 0938-AH89 |
|
| 1285
| Medically Needy Determinations Under Welfare Reform (HCFA-2109-IFC)
| 0938-AH92 |
|
| 1286
| Medicaid Program; Coverage and Payment for Federally Qualified Health Center Services (HCFA-2043-P)
| 0938-AH95 |
|
| 1287
| Portability and Nondiscrimination in the Group Health Insurance Market (HCFA-2890-F)
| 0938-AI08 |
|
| 1288
| Medicare Program; Improvements To the Appeals Process for Medicare Beneficiaries Enrolled in HMOs, CMPs, and HCPPs (HCFA-4024-P)
| 0938-AI11 |
|
| 1289
| Medicaid: Medical Child Support (HCFA-2081-P)
| 0938-AI21 |
|
| 1290
| Medicare/Medicaid Program; User Fees for Information, Products, and Services (HCFA-6021-P)
| 0938-AI46 |
|
| 1291
| Surety Bond Requirements for Comprehensive Outpatient Rehabilitation Facilities, Rehabilitation Agencies, Community Mental Health Centers, and Independent Diagnostic Testing Facilities (HCFA-6005-P)
| 0938-AI48 |
|
| 1292
| Appeals of Carrier Determination That a Supplier Fails To Meet the Requirements for Medicare Billing Privileges (HCFA-6003-P)
| 0938-AI49 |
|
| 1293
| Security Signature Standards (HCFA-0049-F)
| 0938-AI57 |
|
| 1294
| State Plan Requirements for Durable Medical Equipment Providers (HCFA-2007-P)
| 0938-AI63 |
|
| 1295
| Medicare Program; Advance Refunding of Debt and Methodology for Repayment of Loan (HCFA-1777-P)
| 0938-AI75 |
|
| 1296
| Revision of Procedures for Requesting Exceptions to Cost Limits for SNFs and Elimination of Reclassifications (HCFA-1883-P)
| 0938-AI80 |
|
| 1297
| Medicare Program; Medicare Coverage of and Payment for Bone Mass Measurements (HCFA-3004-F)
| 0938-AI89 |
|
| 1298
| Medicare Program; Coverage and Administrative Policies for Clinical Diagnostic Laboratory Tests (HCFA-3250-F)
| 0938-AI92 |
|
| 1299
| Coverage of Religious Non-Medical Health Care Institutions (HCFA-1909-IFC)
| 0938-AI93 |
|
| 1300
| Reporting Outcome and Assessment Information Set (OASIS) Data as Part of the Conditions of Participation for Home Health Agencies (HCFA-3006-IFC)
| 0938-AJ10 |
|
| 1301
| Medicare Program; Criteria and Standards for Evaluating Intermediary and Carrier Performance: Millennium Compliance (HCFA-4002-GNC)
| 0938-AJ15 |
|
| 1302
| Rural Health Clinics: Amendments to Participation Requirements and Payment Provisions, and Establishment of a Quality Assessment and Improvement Program (HCFA-1910-P)
| 0938-AJ17 |
|
| 1303
| Hospital Conditions of Participation: Laboratory Services (HCFA-3 014-P)
| 0938-AJ29 |
|
| 1304
| Medicare Hospice Care Amendments (HCFA-1022-P)
| 0938-AJ36 |
|
| 1305
| Emergency Medical Treatment and Labor Act (EMTALA) (HCFA-1063-P)
| 0938-AJ39 |
|
| 1306
| Medicare/Medicaid and CLIA Programs: Clinical Laboratory Improvement Amendments of 1988 Exemption of Laboratories in the State of California (HCFA-2245-N)
| 0938-AJ47 |
|
| 1307
| Medicare Program: Criteria for Making National Coverage Decision (HCFA-3432-P2)
| 0938-AJ54 |
|
| 1308
| Medicare Program: Prospective Payment System for Inpatient Rehabilitation Hospital Services (HCFA-1069-P)
| 0938-AJ55 |
|
| 1309
| Medicare Program; Sustainable Growth Rate for Fiscal Year 2000 (HCFA-1110-N)
| 0938-AJ60 |
|
| 1310
| Medicare and Medicaid Programs; Programs for All-Inclusive Care for the Elderly (PACE) (HCFA-1903-IFC)
| 0938-AJ63 |
|
| 1311
| State Health Insurance Assistance Program (SHIP) (HCFA-4005-IFC)
| 0938-AJ67 |
|
| 1312
| Clinical Social Worker Services (HCFA-1088-P)
| 0938-AJ71 |
|
| 1313
| Medicaid Disproportionate Share Hospital Payments-Institutions for Mental Disease (HCFA-2062-N)
| 0938-AJ74 |
|
| 1314
| HHA Surety Bond (HCFA-6001-P)
| 0938-AJ81 |
|
| 1315
| Medicare Program Update of Ambulatory Surgical Center Payment Rates Effective for Services On or After October 1, 1999 (HCFA-1085-N)
| 0938-AJ86 |
|
| 1316
| Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities-Update (HCFA-1112-P)
| 0938-AJ93 |
|
| 1317
| Use of Restraint and Seclusion in Residential Treatment Facilities Providing Inpatient Psychiatric Services to Individuals Under Age 21 (HCFA-2065-IFC)
| 0938-AJ96 |
|
| 1318
| Supplier Standards Related to Training Requirements for Oxygen, Orthotics and Prosthetics (HCFA-6010-NPRM)
| 0938-AJ98 |
|
| 1319
| Conditions of Participation for Intermediate Care Facilities for the Mentally Retarded
| 0938-AJ99 |
|
| 1320
| Non-Federal Governmental Plans Exempt From HIPAA (HCFA-2033-IFC)
| 0938-AK00 |
|
| 1321
| Changes to the Appeals Process for Beneficiaries Receiving Home Health Services in the Fee For Service Program (HCFA-4006-IFC)
| 0938-AK10 |
|
| 1322
| Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2001 (HCFA-1120-P)
| 0938-AK11 |
|
| 1323
| Hospice Wage Index (HCFA-1135-N)
| 0938-AK13 |
|
| 1324
| Practice Expense Data Collection (HCFA-1111-IFC)
| 0938-AK14 |
|
| 1325
| HIPPA Program; Bona Fide Wellness Programs (HCFA-2078-P)
| 0938-AK19 |
|
| 1326
| Providers of the Balanced Budget and Refinement Act; Hospital Inpatient Payments, Rates and Costs of Graduate Medical Education (HCFA-1131-IFC)
| 0938-AK20 |
|
| 1327
| Application of Federal Financial Participation Limits (HCFA-2086-P)
| 0938-AK22 |
|
| 1328
| Conditions of Participation of Intermediate Care Facilities for Persons With Mental Retardation (HCFA-3046-P)
| 0938-AK23 |
|
| 1329
| Clinical Lab Requirements-Revisions to Regs Implementing CLIA (HCFA-2226-F)
| 0938-AK24 |
|
| 1330
| Prospective Payment System for Hospital Outpatient Services: Exception to the Provider-Based Location Criteria for PPS-Exempt Facilities (HCFA-1143-P)
| 0938-AK25 |
|
| 1331
| Criteria and Standards for Evaluating Intermediary and Carrier Performance During FY 2001 (HCFA-4010-GNC)
| 0938-AK26 |
|
| 1332
| Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts for Calendar Year 2001 (HCFA-8007-N)
| 0938-AK27 |
|
| 1333
| Mandatory Transmission of Outcome and Assessment Info. Set for Non-Medicare/Medicaid Patients in Home Health Agencies and Continued Delay of Requirements for Patients Receiving Personal Care Services
| 0938-AK28 |
|
| 1334
| Removal of the Requirements for the Cardiac Pacemaker Registry (HCFA-3045-F)
| 0938-AK29 |
|
| 1335
| Fire Safety Requirements for RNHCI, ASC, Hospices, PACE, Hospitals, and Long-Term Care Facilities
| 0938-AK35 |
|
| 1336
| Conforming Regulations Changes and Statutory Revisions for Approval and Oversight of Accreditation Organizations
| 0938-AK36 |
| Health Care Financing Administration--Completed Actions
|
|
| Sequence Number | Title | Regulation Identifier Number |
|
| 1337
| Payment for Clinical Diagnostic Laboratory Tests (HCFA-1309-F)
| 0938-AB50 |
|
| 1338
| Survey Requirements and Alternative Sanctions for Home Health Agencies (HCFA-2169-F)
| 0938-AE39 |
|
| 1339
| Changes to the Long-Term Care Facility Survey Process (HCFA-3175-FC)
| 0938-AF02 |
|
| 1340
| Requirements for Certain Health Insuring Organizations and OBRA `90 Technical Amendments (HCFA-1018-F)
| 0938-AF15 |
|
| 1341
| Provider Reimbursement Determinations and Appeals (HCFA-1727-P)
| 0938-AF28 |
|
| 1342
| Alternative Sanctions for Psychiatric Hospitals (HCFA-2191-P)
| 0938-AF32 |
|
| 1343
| Medicaid: Outstationed Intake Locations for Certain Low-Income Pregnant Women, Infants, and Children Under Age 19 (HCFA-2052-F)
| 0938-AF69 |
|
| 1344
| Assessing Interest Against Medicare Secondary Payer (MSP) Debts (HCFA-6108-P)
| 0938-AF87 |
|
| 1345
| Revised Medicaid Management Information Systems (HCFA-2038-FN)
| 0938-AG10 |
|
| 1346
| Medicare Program: Limitations on Medicare Coverage of Intermittent Positive Pressure Breathing Machine Therapy (HCFA-3781-FN)
| 0938-AG44 |
|
| 1347
| Definition of Skilled Nursing Facility (SNF) for Coverage of Durable Medical Equipment (DME) and Home Health Services (HCFA-1834-P)
| 0938-AH16 |
|
| 1348
| Payment Amount if Customary Charges Are Less Than Reasonable Costs (HCFA-1860-FC)
| 0938-AH49 |
|
| 1349
| Limitations on Liability (HCFA-4859-FC)
| 0938-AH51 |
|
| 1350
| Medicaid Hospice Care (HCFA-2016-P)
| 0938-AH65 |
|
| 1351
| Medicare Technical Conforming Amendments (HCFA-1858-FC)
| 0938-AH67 |
|
| 1352
| Elimination of Certain Requirements for Peer Review Organizations in the Utilization and Quality Review Process and a Change in the Length of Peer Review Organization Contracts (HCFA-3235-FC)
| 0938-AH68 |
|
| 1353
| Determination of Substandard Care in SNFs and NFs (HCFA-2240-P)
| 0938-AH69 |
|
| 1354
| Waiver of Staffing Requirements for End Stage Renal Disease (ESRD) Facilities Participating in an Experiment (HCFA-2236-GNC)
| 0938-AH72 |
|
| 1355
| Medicare Program; Medicare Integrity Program (HCFA-7020-F)
| 0938-AI09 |
|
| 1356
| State Child Health; Implementing Regulations for the State Children's Health Insurance Program (HCFA-2006-F)
| 0938-AI28 |
|
| 1357
| Medicare Program; Medicare+Choice Program (HCFA-1030-FC)
| 0938-AI29 |
|
| 1358
| Health Insurance Reform: Standards for Electronic Transactions (HCFA-0149-F)
| 0938-AI58 |
|
| 1359
| State Child Health; State Children's Health Insurance Program Allotments and Payments to States (HCFA-2114-F)
| 0938-AI65 |
|
| 1360
| Elimination of Application of Federal Financial Participation Limits (HCFA-2111-IFC)
| 0938-AI73 |
|
| 1361
| Medicaid Program; Changes to Eligibility of Non-U.S. Citizens (HCFA-2108-P)
| 0938-AI74 |
|
| 1362
| Health Insurance Reform Universal Health Care Identifier (HCFA-0048-NOI)
| 0938-AI91 |
|
| 1363
| Peer Review Organization Contracts: Solicitation of Statements of Interest From In-State Organizations (HCFA-3009-N)
| 0938-AI99 |
|
| 1364
| HHS' Recognition of NAIC Model Standards for Regulation of Medigap Policy (HCFA-2025-N)
| 0938-AJ07 |
|
| 1365
| Home Health Prospective Payment System (HCFA-1059-F)
| 0938-AJ24 |
|
| 1366
| Decision on the Funding for the AIDS Healthcare Foundation START Program, (HCFA-2041-N)
| 0938-AJ43 |
|
| 1367
| Federal Enforcement in Group and Individual Health Insurance Markets (HCFA-2019-FC)
| 0938-AJ48 |
|
| 1368
| Schedules of Per Visit and Per Beneficiary Limitation on Home Health Agency Cost (HCFA-1060-NC)
| 0938-AJ57 |
|
| 1369
| Reapplication of the Community Health Accreditation Program, Incorporated (CHAP) for Continued Approval of Deeming Authority for Health Care Agencies (HHAs) (HCFA-2059-FN)
| 0938-AJ69 |
|
| 1370
| State Allotments for Payments of Medicare Part B Premiums for Qualified Individuals: Federal Fiscal Year 2000 (HCFA-2063-N)
| 0938-AJ72 |
|
| 1371
| Children's Health Insurance Program; Final Allotments to States, Commonwealths and Territories for Fiscal Years 1998 and 1999 (HCFA-2064-N)
| 0938-AJ77 |
|
| 1372
| Announcement of Additional Applications From Hospitals Requesting Waivers for Organ Procurement Service Areas (HCFA-1055-N)
| 0938-AJ79 |
|
| 1373
| Monthly Actuary Rates and Monthly Supplementary Medical Insurance Premium Rates Beginning January 1, 2000 (HCFA-8006-N)
| 0938-AJ80 |
|
| 1374
| Payment for Upgraded Durable Medical Equipment (HCFA-1084-P)
| 0938-AJ82 |
|
| 1375
| Inpatient Hospital Deductible and Extended Care Services for Coinsurance Amounts for FY 2000 (HCFA-8005-N)
| 0938-AJ83 |
|
| 1376
| Part A Premium for FY 2000 for the Uninsured, Aged and for Certain Disabled Individuals Who Have Exhausted Other Entitlements (HCFA-8004-N)
| 0938-AJ84 |
|
| 1377
| Coverage of, and Payment of, Paramedic Intercept Ambulance Services (HCFA-1813-F)
| 0938-AJ87 |
|
| 1378
| Criteria and Standards for Evaluating Intermediary and Carrier Performance During FY 2000 (HCFA-4009-GNC)
| 0938-AJ88 |
|
| 1379
| Medicare Graduate Medical Education Consortia (HCFA-1094-N)
| 0938-AJ89 |
|
| 1380
| Sustainable Growth Rate for FY 2000 (HCFA-1110-N)
| 0938-AJ90 |
|
| 1381
| Medicare Program; Medicare Disproportionate Share (DSH) Adjustment Calculation: Change in the Treatment of Days in States With 1115 Expansion Waivers (HCFA-1124-IFC)
| 0938-AJ92 |
|
| 1382
| State Children's Health Insurance Program; Final Allotments to States, Commonwealths, and Territories for Fiscal Year 2000 (HCFA-2067-N)
| 0938-AJ94 |
|
| 1383
| Process for Requesting Recognition of New Technologies and Certain Drugs, Biologicals and Medical Devices for Special Payment Under Hospital Outpatient PPS (HCFA-1128-N)
| 0938-AK01 |
|
| 1384
| Schedules of Per Visit and Per Beneficiary Limitations on HHA Costs for Cost Reporting Periods Beginning On or After October 1, 2000 (HCFA-1108-NC)
| 0938-AK03 |
|
| 1385
| Reporting Quality Assurance and Performance Improvement Data as Part of the Conditions for Coverage for End Stage Renal Disease Facilities (HCFA-3048-N)
| 0938-AK05 |
|
| 1386
| Medicare Program; Deductible Amount for Medigap High Deductible Options for Calendar Year 2000 (HCFA-2893-N)
| 0938-AK06 |
|
| 1387
| Changes to the Hospital Inpatient Perspective Payment Systems and Fiscal Year 2001 Rates (HCFA-1118-F)
| 0938-AK09 |
|
| 1388
| Health Care and Employment Support Grants for People With Disabilities Beginning Fiscal Year 2000 (HCFA-2076-N)
| 0938-AK16 |